Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R BAKER

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|March 1, 1972
Irreversible enzyme inhibitors. 192. Hydrophobic bonding to some dehydrogenases with 5-substituted-4-hydroxyquinoline-3-carboxylic acidsB R Baker, R R Bramhall
Journal of Medicinal Chemistry|September 1, 1976
Irreversible enzyme inhibitors. Inhibitors of guinea pig complement derived by quaternization of substituted pyridines with benzyl halidesM H Doll, B R Baker
CDA Journal|October 1, 1985
Hepatitis B: recent advances and 1986 previewJ A Cottone, B R Baker
The Journal of Organic Chemistry|March 19, 2010
Biotin; 3,4-trans-diaminothiophaneG B BROWN, B R BAKER
Journal of Medicinal Chemistry|December 1, 1974
Enzyme inhibitors. Inhibition of brain choline acetyltransferase by derivatives of 4-styrylpyrimidineR E Gibson, B R Baker
The Journal of the Royal College of General Practitioners|September 1, 1978
Mental state and other prognostic factors in femoral fractures of the elderlyB R Baker, T Duckworth, E Wilkes
The Journal of Organic Chemistry|March 19, 2010
Biotin; synthesis of dl-epibiotinB R BAKER, W L McEWEN, W N KINLEY
Dentistry (American Student Dental Association)|April 1, 1986
Sexual diseases important to dentistry. Clinical diagnoses and treatmentG P Terezhalmy, J A Cottone, B R Baker
Journal of Medicinal Chemistry|March 1, 1970
Irreversible enzyme inhibitors. 168. Irreversible inhibition of dihydrofolate reductase and cell wall transport by pyrimidines and dihydro-s-triazines with pyridinium side chainsB R Baker, N M Vermeulen, A J Ryan
Journal of Medicinal Chemistry|November 1, 1970
Irreversible enzyme inhibitors. CLXXIV. Metabolism of 4-(p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)hydrocinnamido)-o-toluenesulfonyl fluoride (NSC-113423), an active-site-directed irreversible inhibitor of dihydrofolic reductaseA J Ryan, N M Vermeulen, B R Baker
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|March 1, 1972
Irreversible enzyme inhibitors. 192. Hydrophobic bonding to some dehydrogenases with 5-substituted-4-hydroxyquinoline-3-carboxylic acidsB R Baker, R R Bramhall
Journal of Medicinal Chemistry|September 1, 1976
Irreversible enzyme inhibitors. Inhibitors of guinea pig complement derived by quaternization of substituted pyridines with benzyl halidesM H Doll, B R Baker
CDA Journal|October 1, 1985
Hepatitis B: recent advances and 1986 previewJ A Cottone, B R Baker
The Journal of Organic Chemistry|March 19, 2010
Biotin; 3,4-trans-diaminothiophaneG B BROWN, B R BAKER
Journal of Medicinal Chemistry|December 1, 1974
Enzyme inhibitors. Inhibition of brain choline acetyltransferase by derivatives of 4-styrylpyrimidineR E Gibson, B R Baker
The Journal of the Royal College of General Practitioners|September 1, 1978
Mental state and other prognostic factors in femoral fractures of the elderlyB R Baker, T Duckworth, E Wilkes
The Journal of Organic Chemistry|March 19, 2010
Biotin; synthesis of dl-epibiotinB R BAKER, W L McEWEN, W N KINLEY
Dentistry (American Student Dental Association)|April 1, 1986
Sexual diseases important to dentistry. Clinical diagnoses and treatmentG P Terezhalmy, J A Cottone, B R Baker
Journal of Medicinal Chemistry|March 1, 1970
Irreversible enzyme inhibitors. 168. Irreversible inhibition of dihydrofolate reductase and cell wall transport by pyrimidines and dihydro-s-triazines with pyridinium side chainsB R Baker, N M Vermeulen, A J Ryan
Journal of Medicinal Chemistry|November 1, 1970
Irreversible enzyme inhibitors. CLXXIV. Metabolism of 4-(p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)hydrocinnamido)-o-toluenesulfonyl fluoride (NSC-113423), an active-site-directed irreversible inhibitor of dihydrofolic reductaseA J Ryan, N M Vermeulen, B R Baker
Pageof 7